These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32952937)

  • 21. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered CRISPR Systems for Next Generation Gene Therapies.
    Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
    ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
    Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
    BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR system in filamentous fungi: Current achievements and future directions.
    Deng H; Gao R; Liao X; Cai Y
    Gene; 2017 Sep; 627():212-221. PubMed ID: 28625564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-content CRISPR screening in tumor immunology.
    Holcomb EA; Pearson AN; Jungles KM; Tate A; James J; Jiang L; Huber AK; Green MD
    Front Immunol; 2022; 13():1041451. PubMed ID: 36479127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing.
    Waryah CB; Moses C; Arooj M; Blancafort P
    Methods Mol Biol; 2018; 1767():19-63. PubMed ID: 29524128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.
    Naeimi Kararoudi M; Hejazi SS; Elmas E; Hellström M; Naeimi Kararoudi M; Padma AM; Lee D; Dolatshad H
    Front Immunol; 2018; 9():1711. PubMed ID: 30233563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes.
    Evers B; Jastrzebski K; Heijmans JP; Grernrum W; Beijersbergen RL; Bernards R
    Nat Biotechnol; 2016 Jun; 34(6):631-3. PubMed ID: 27111720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics approaches to analyzing CRISPR screen data: from dropout screens to single-cell CRISPR screens.
    Zhao Y; Zhang M; Yang D
    Quant Biol; 2022 Dec; 10(4):307-320. PubMed ID: 36937794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR editing in biological and biomedical investigation.
    Huang J; Wang Y; Zhao J
    J Cell Physiol; 2018 May; 233(5):3875-3891. PubMed ID: 28786481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens.
    Mattson NM; Chan AKN; Miyashita K; Mukhaleva E; Chang WH; Yang L; Ma N; Wang Y; Pokharel SP; Li M; Liu Q; Xu X; Chen R; Singh P; Zhang L; Elsayed Z; Chen B; Keen D; Pirrotte P; Rosen ST; Chen J; LaBarge MA; Shively JE; Vaidehi N; Rockne RC; Feng M; Chen CW
    Nat Struct Mol Biol; 2024 Mar; 31(3):465-475. PubMed ID: 38316881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic Amplifications Cause False Positives in CRISPR Screens.
    Sheel A; Xue W
    Cancer Discov; 2016 Aug; 6(8):824-6. PubMed ID: 27485003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR Libraries and Screening.
    Poirier JT
    Prog Mol Biol Transl Sci; 2017; 152():69-82. PubMed ID: 29150005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions.
    Gebre M; Nomburg JL; Gewurz BE
    Viruses; 2018 Jan; 10(2):. PubMed ID: 29385696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.